How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

6,334 results for

Depression Screening Tools

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

141. Depression: Adult and Adolescent

by the individual patient. 2 Major Changes as of December 2018 New Previous Recommendations for women who are pregnant, postpartum, or currently on antidepressants and considering pregnancy are now in a separate guideline. Previously, recommendations for pregnant and postpartum women were included in this guideline. For adults, the standalone depression screening tool (PHQ-9) has been replaced by a more expansive Annual Behavioral Health Questionnaire. For adolescents, the PHQ-9A with additional screening (...) questions (ADQ) on the back page remains the recommended tool. Previously, depression screening for adults was done by a standalone PHQ-9 tool with additional depression questions on the back page. Omega-3s and SAMe are considered options for patients who are reluctant to take traditional antidepressants. Previously, omega-3s and SAMe were not recommended for treatment of depression due to insufficient evidence. Bright light therapy is now recommended as a non- pharmacologic option for depression

2017 Kaiser Permanente Clinical Guidelines

142. Guidelines for Adolescent Depression in Primary Care (GLAD-PC): Part I. Practice Preparation, Identification, Assessment, and Initial Management

were screened out, leaving a total of 8 relevant articles. A full report of all the literature reviews is available on request. Results Literature Reviews Practice Preparation Once PC practices have buy-in from administrative and clinical staff to improve depression care for youth, 2 important steps are necessary. First, before practices embark on screening for or identifying youth who are at risk for depression, training in such issues as appropriate screening tools, assessment and diagnostic (...) complex or severe patients. , Identification and Assessment In 2009, after the publication of the GLAD-PC, the United States Preventive Services Task Force (USPSTF) endorsed universal adolescent depression screening in teenagers ages 12 to 18 years. This recommendation was based on evidence that there are validated depression screening tools that work in an adolescent PC population and the evidence that there are treatments that work for the identified population. , On the basis of our review to date

2018 American Academy of Pediatrics

143. Guidelines for Adolescent Depression in Primary Care (GLAD-PC): Part II. Treatment and Ongoing Management

editor-chosen studies with the greatest impact on clinical care. This policy is a revision of the policy in Guidelines for Adolescent Depression in Primary Care (GLAD-PC): Part II. Treatment and Ongoing Management Amy H. Cheung , Rachel A. Zuckerbrot , Peter S. Jensen , Danielle Laraque , Ruth E.K. Stein , GLAD-PC STEERING GROUP Abstract OBJECTIVES: To update clinical practice guidelines to assist primary care (PC) in the screening and assessment of depression. In this second part of the updated (...) . , Thus, it will be necessary to identify effective methods for disseminating information and provide assistance to PC clinicians in changing practice. Researchers should build on this work by piloting and evaluating methods, tools, and strategies to facilitate the adoption of these guidelines for the management of adolescent depression in PC settings. Researchers should also explore optimal methods for helping clinicians and their clinical settings address the range of obstacles that may interfere

2018 American Academy of Pediatrics

144. Assessment and Interventions for Perinatal Depression

Appendix B: Best Practice Guideline Development Process . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 127 Appendix C: Process for Systematic Review and Search Strategy . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 128 Appendix D: Diversity among Pregnant and Postpartum Persons with Perinatal Depression . . . . . . . . . . . . . . . . . . . 134 Appendix E: Examples of Perinatal Depression Screening Tools (...) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 143 Appendix F: Examples of Perinatal Depression Assessment Tools . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 147 Appendix G: Considerations for Selecting a Perinatal Depression Screening Tool . . . . . . . . . . . . . . . . . . . . . . . . . . . 149 Appendix H: Responding to an Identified Risk of Maternal Suicide . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 152 Appendix I: Edinburgh Postnatal Depression Scale

2018 Registered Nurses' Association of Ontario

145. Got Depression? I can answer that in two questions!

Got Depression? I can answer that in two questions! Tools for Practice is proudly sponsored by the Alberta College of Family Physicians (ACFP). ACFP is a provincial, professional voluntary organization, representing more than 4,800 family physicians, family medicine residents, and medical students in Alberta. Established over sixty years ago, the ACFP strives for excellence in family practice through advocacy, continuing medical education and primary care research. www.acfp.ca January 15, 2018 (...) Got Depression? I can answer that in two questions! Clinical Question: What is the diagnostic accuracy of the 2-question screen for identifying depression in primary care? Bottom Line: The 2-question screen is good at ruling out (but not ruling in) depression in primary care. Up to 50% of patients will test positive and should have more thorough evaluation to confirm depression diagnosis. Whether screening alters outcomes is debatable, but the 2-question screen may be reasonable for case- finding

2018 Tools for Practice

146. Development and use of a clinical decision support tool for behavioral health screening in primary care clinics (Full text)

Development and use of a clinical decision support tool for behavioral health screening in primary care clinics Screening, brief intervention, and referral for treatment (SBIRT) for behavioral health (BH) is a key clinical process. SBIRT tools in electronic health records (EHR) are infrequent and rarely studied. Our goals were 1) to design and implement SBIRT using clinical decision support (CDS) in a commercial EHR; and 2) to conduct a pragmatic evaluation of the impact of the tools (...) on clinical outcomes.A multidisciplinary team designed SBIRT workflows and CDS tools. We analyzed the outcomes using a retrospective descriptive convenience cohort with age-matched comparison group. Data extracted from the EHR were evaluated using descriptive statistics.There were 2 outcomes studied: 1) development and use of new BH screening tools and workflows; and 2) the results of use of those tools by a convenience sample of 866 encounters. The EHR tools developed included a flowsheet for documenting

2017 Applied clinical informatics PubMed abstract

147. Reliability and validity of the Turkish version of the fibromyalgia rapid screening tool (FiRST) (Full text)

Reliability and validity of the Turkish version of the fibromyalgia rapid screening tool (FiRST) [Purpose] An easy-to-use, psychometrically validated screening tool for fibromyalgia is needed. This study aims to evaluate the reliability and validity of the Turkish version of the Fibromyalgia Rapid Screening Tool by correlating it with 2013 American College of Rheumatology alternative diagnostic criteria and the Hospital Anxiety and Depression Scale. [Subjects and Methods] Subjects were 269 (...) Physical Medicine and Rehabilitation clinic outpatients. Patients completed a questionnaire including the Fibromyalgia Rapid Screening Tool (twice), 2013 American College of Rheumatology alternative diagnostic criteria, and the Hospital Anxiety and Depression Scale. Scale reliability was examined by test-retest. The 2013 American College of Rheumatology alternative diagnostic criteria was used for comparison to determine criterion validity. The sensitivity, specificity, and positive and negative

2017 Journal of physical therapy science PubMed abstract

148. A Screening Tool to Measure Eye Contact Avoidance in Boys with Fragile X Syndrome (Full text)

A Screening Tool to Measure Eye Contact Avoidance in Boys with Fragile X Syndrome We examined the reliability, validity and factor structure of the Eye Contact Avoidance Scale (ECAS), a new 15-item screening tool designed to measure eye contact avoidance in individuals with fragile X syndrome (FXS). Internal consistency of the scale was acceptable to excellent and convergent validity with the Social Responsiveness Scale, Second Edition (SRS-2) and the Anxiety, Depression, and Mood Scale (ADAMS (...) ) was good. Boys with a comorbid ASD diagnosis obtained significantly higher scores on the ECAS compared to boys without ASD, when controlling for communication ability. A confirmatory factor analysis indicated that a two-factor model (avoidance and aversion) provided an excellent fit to the data. The ECAS appears to be a promising reliable and valid tool that could be employed as an outcome measure in future pharmacological/behavioral treatment trials for FXS.

2017 Journal of autism and developmental disorders PubMed abstract

149. A Digital Tool to Promote Alcohol and Drug Use Screening, Brief Intervention, and Referral to Treatment Skill Translation: A Mobile App Development and Randomized Controlled Trial Protocol (Full text)

about SBIRT), (2) apply skills with patients (ie, build confidence and perceived behavioral control), and (3) report performance data (ie, increase accountability and social norms and/or influence). The app includes depression and anxiety screening tools due to high comorbidity with substance use. A randomized controlled trial (RCT) is in progress among health and social service learners (N=200) recruited from 3 universities and 6 different training programs in nursing, social work, internal (...) A Digital Tool to Promote Alcohol and Drug Use Screening, Brief Intervention, and Referral to Treatment Skill Translation: A Mobile App Development and Randomized Controlled Trial Protocol Translation of knowledge and skills from classroom settings to clinical practice is a major challenge in healthcare training, especially for behavioral interventions. For example, screening, brief intervention, and referral to treatment (SBIRT) is a highly-promoted approach to identifying and treating

2017 JMIR Research Protocols Controlled trial quality: uncertain PubMed abstract

150. Screen-Based Distraction Tool for Preoperative Preparation

Screen-Based Distraction Tool for Preoperative Preparation Screen-Based Distraction Tool for Preoperative Preparation - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Screen-Based Distraction Tool (...) Allocation: Randomized Intervention Model: Parallel Assignment Masking: Single (Outcomes Assessor) Primary Purpose: Treatment Official Title: Screen-Based Distraction Tool for Preoperative Preparation Actual Study Start Date : January 2017 Actual Primary Completion Date : January 2018 Actual Study Completion Date : January 2018 Resource links provided by the National Library of Medicine related topics: Arms and Interventions Go to Arm Intervention/treatment Active Comparator: Tablet Preoperative patients

2017 Clinical Trials

151. Validation of the STarT Back Screening Tool in the Military

Validation of the STarT Back Screening Tool in the Military Validation of the STarT Back Screening Tool in the Military - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Validation of the STarT Back Screening (...) Information provided by (Responsible Party): Dan Rhon, Brooke Army Medical Center Study Details Study Description Go to Brief Summary: This is a trial to validate the use of the STarT Back Screening Tool (SBST) in the Military Health System for patients with low back pain presenting to primary care. Condition or disease Intervention/treatment Phase Low Back Pain Lumbago Radiculopathy Intervertebral Disc Disorder Procedure: Risk Stratified Care Procedure: Usual Care Not Applicable Detailed Description

2017 Clinical Trials

152. Performance of Edmonton Frail Scale on frailty assessment: its association with multi-dimensional geriatric conditions assessed with specific screening tools. (Full text)

Performance of Edmonton Frail Scale on frailty assessment: its association with multi-dimensional geriatric conditions assessed with specific screening tools. The aim of this study was to evaluate the performance of Edmonton Frail Scale (EFS) on frailty assessment in association with multi-dimensional conditions assessed with specific screening tools and to explore the prevalence of frailty by gender.We enrolled 366 hospitalised patients (women\men: 251\115), mean age 81.5 years. The EFS (...) was given to the patients to evaluate their frailty. Then we collected data concerning cognitive status through Mini-Mental State Examination (MMSE), health status (evaluated with the number of diseases), functional independence (Barthel Index and Activities Daily Living; BI, ADL, IADL), use of drugs (counting of drugs taken every day), Mini Nutritional Assessment (MNA), Geriatric Depression Scale (GDS), Skeletal Muscle Index of sarcopenia (SMI), osteoporosis and functionality (Handgrip strength

2017 BMC Geriatrics PubMed abstract

153. Recommendation on screening adults for asymptomatic thyroid dysfunction in primary care

Recommendation on screening adults for asymptomatic thyroid dysfunction in primary care Recommendation on screening adults for asymptomatic thyroid dysfunction in primary care | CMAJ Main menu User menu Search Search for this keyword Search for this keyword Guideline Recommendation on screening adults for asymptomatic thyroid dysfunction in primary care Richard Birtwhistle , Kate Morissette , James A. Dickinson , Donna L. Reynolds , Marc T. Avey , Francesca Reyes Domingo , Rachel Rodin (...) of Family Medicine and Community Health Sciences (Dickinson), University of Calgary, Alta.; Dalla Lana School of Public Health and Department of Family and Community Medicine (Reynolds), University of Toronto, Ont.; Department of Psychiatry (Thombs), Jewish General Hospital and McGill University, Montréal, Que. KEY POINTS The Canadian Task Force on Preventive Health Care strongly recommends against screening for thyroid dysfunction in asymptomatic nonpregnant adults. Screening for thyroid dysfunction

2019 Canadian Task Force on Preventive Health Care

154. How depressed is "depressed"? A systematic review and diagnostic meta-analysis of optimal cut points for the Beck Depression Inventory revised (BDI-II). (Abstract)

How depressed is "depressed"? A systematic review and diagnostic meta-analysis of optimal cut points for the Beck Depression Inventory revised (BDI-II). The Beck Depression Inventory revised (BDI-II) is widely used tool to screen for depression. The aim of the present study was to systematically review and synthesize studies that determined optimal cut points for the BDI-II.We identified 27 studies that tried to identify optimal cut points for the BDI-II. Study quality was assessed using (...) recommendations for practitioners. Taking into account these fluctuations, we find that practitioners should use different cut points to screen for depression in primary care and healthy populations (a score of 13 and higher indicates depression) and psychiatric settings (a score of 19 and higher indicates depression). Methods to describe this variability and meta-analysis to synthesize findings across studies should be used more widely.

2020 Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation

155. Is the BPRS-5 subscale of the psychotic depression assessment scale a reliable screening tool for psychotic depression?: Results from the CRESCEND Study. (Abstract)

Is the BPRS-5 subscale of the psychotic depression assessment scale a reliable screening tool for psychotic depression?: Results from the CRESCEND Study. The detection of psychotic depression (PD) among patients with depressive disorders is important for both treatment and monitoring. Therefore, in continuation of our previous work, this study aimed to test the ability of the five-item Brief Psychiatric Rating Scale (BPRS-5) of the Psychotic Depression Assessment Scale (PDAS) in separating (...) patients with psychotic depression from those with non-psychotic depression (non-PD) and to compare this discriminative validity to that of other item sets.A receiver operating characteristics curve was used to identify the optimal cut-off score of the BPRS-5 subscale for sensitive and specific distinction between PD and non-PD in a sample of 494 patients with depressive disorders (53 with PD and 441 with non-PD).Using an optimal cut-off score of 1, the sensitivity and the specificity of the BPRS-5

2014 Journal of Affective Disorders

156. The utility of the Edinburgh Depression Scale as a screening tool for depression in Parkinson's disease. (Full text)

The utility of the Edinburgh Depression Scale as a screening tool for depression in Parkinson's disease. This study aimed to evaluate the Edinburgh Depression Scale (EDS) as a screening tool for use in a Parkinson's disease (PD) population. Many commonly used depression scales include items relating to somatic symptoms that also occur in PD, which could potentially result in inaccurate reporting of depressive symptoms. The EDS is a scale that incorporates no somatic items.One hundred twenty (...) or major depression. The performance characteristics at a range of thresholds were compared.A cut-off score of 10/11 gave maximal discriminant validity, with 74% sensitivity, 92% specificity and 64% positive predictive value for the identification of any depression according to DSM-IV criteria.This study suggests that the EDS is both a valid and potentially useful instrument that can be used as a quick self-completion questionnaire for screening for depression in people who have PD.Copyright © 2014

2014 International Journal of Geriatric Psychiatry PubMed abstract

157. Accuracy of case-finding tools for depression in long term care

Accuracy of case-finding tools for depression in long term care Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web address: Timing and effect measures (...) Timing and effect measures Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web address: Context and rationale Inclusion criteria: Exclusion criteria: Inclusion criteria: Exclusion criteria: Inclusion criteria: Exclusion criteria: Inclusion criteria: Exclusion criteria: Inclusion criteria: Exclusion criteria: Example: Screening will be performed in two phases, namely initial screening based on title and abstract, followed by full-text screening of the eligible articles

2018 PROSPERO

158. Screening and Management of Bleeding Disorders in Adolescents With Heavy Menstrual Bleeding

tests. The obstetrician–gynecologist should be aware of risk factors and comorbidities associated with bleeding disorders. Medical History When obtaining a medical history, it is important to identify risk factors for bleeding disorders as well as medical conditions that would alter management. See for a recommended screening tool for adolescent patients who report heavy menstrual bleeding. Adolescents who meet the criteria detailed in Box 1 should undergo laboratory screening for a bleeding (...) Screening and Management of Bleeding Disorders in Adolescents With Heavy Menstrual Bleeding Screening and Management of Bleeding Disorders in Adolescents With Heavy Menstrual Bleeding - ACOG Menu ▼ Screening and Management of Bleeding Disorders in Adolescents With Heavy Menstrual Bleeding Page Navigation ▼ Number 785 Committee on Adolescent Health Care This Committee Opinion was developed by the American College of Obstetricians and Gynecologists’ Committee on Adolescent Health Care

2019 American College of Obstetricians and Gynecologists

159. Screen-based activities and children and young people’s mental health and psychosocial wellbeing: a systematic map of reviews

: the nature of the screen-based activity examined; the aims of the review; the mental health outcomes assessed; the population focus; and the size of the evidence base and type of synthesis undertaken. Critical appraisal: We assessed the methodological quality of included reviews of quantitative studies by adapting the AMSTAR 2 criteria (Shea et al., 2017). We did not undertake appraisal of the reviews of qualitative studies because of the current lack of a validated/agreed tool for judging the quality (...) ). - Fewer reviews attempted to explore the risk factors (n=6) or consequences (n=11) of screen- based activities by conducting syntheses of longitudinal data. - Even fewer reviews explored CYP’s experience of engagement with screen-based activities by conducting a qualitative evidence synthesis (n=4). Outcomes A wide spectrum of mental health and psychosocial outcomes were investigated across the reviews. These included commonly recognised mental health outcomes such as depression and anxiety

2018 EPPI Centre

160. Helping physicians fatigued by TSH Screening and Subclinical Hypothyroidism

Helping physicians fatigued by TSH Screening and Subclinical Hypothyroidism Tools for Practice is proudly sponsored by the Alberta College of Family Physicians (ACFP). ACFP is a provincial, professional voluntary organization, representing more than 4,800 family physicians, family medicine residents, and medical students in Alberta. Established over sixty years ago, the ACFP strives for excellence in family practice through advocacy, continuing medical education and primary care research (...) . www.acfp.ca December 9, 2019 (en français) Helping physicians fatigued by TSH Screening and Subclinical Hypothyroidism Clinical Question: Is there evidence for screening for thyroid function or treating subclinical hypothyroidism? Bottom Line: There is no randomized controlled trial (RCT) of screening for thyroid function [ordering thyroid stimulating hormone (TSH) in non-pregnant healthy people]. Despite approximately 20 RCTs, there are no patient-oriented benefits (like preventing cardiovascular disease

2019 Tools for Practice

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>